Zhitong Finance App News, Sinopharm Hyundai (600420.SH) issued an announcement. Recently, the company received the “Drug Registration Certificate” for voglibose tablets approved and issued by the State Drug Administration. Votribose tablets are a commonly used oral hypoglycemic drug. They are mainly used to improve postprandial hyperglycemia in patients with type 2 diabetes. They are suitable for patients receiving diet therapy or exercise therapy when there is no obvious effect, or when patients use oral hypoglycemic drugs or insulin preparations in addition to diet therapy or exercise therapy without significant results.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.